2014 ASCO AM Public - Sunday

267

Chicago, IL - The 2014 ASCO Annual Meeting - "Christopher Sweeney, MBBS Abstract #LBA2: ""Impact on overall survival (OS)_with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial,"" Plenary Session Keyword: AM14_Christopher_Sweeney" at the American Society of Clinical Oncology Annual Meeting here today, Sunday June 1, 2014. More than 30,000 physicians, researchers, health care professionals, cancer survivors and patient advocates are expected to attend the 50th Anniversary meeting at the McCormick Convention Center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Phil McCarten 2014 Technical Questions: todd@medmeetingimages.com